)
Visual24 Oct 2025
The rise of Alphabet
Clarity Pharmaceuticals (CU6) investor relations material
Clarity Pharmaceuticals H2 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.H2 2025 earnings summary4 Sep, 2025
Executive summary
Achieved significant clinical milestones, including progression of two Phase III trials for SAR-bisPSMA in prostate cancer and positive Phase II data for SARTATE (NETs) and SAR-Bombesin (prostate cancer).
Raised $203.6 million in a placement, strengthening the cash position to $277 million pro-forma at June 2025.
Refocused strategy on high-value, high-probability clinical programs to extend cash runway amid market volatility.
Expanded manufacturing and supply chain agreements to support anticipated commercial rollout.
Financial highlights
Net loss for the year ended 30 June 2025 was $64.3 million, up from $42.3 million in 2024, driven by increased R&D expenditure.
Research and development expenses rose to $66.9 million (up $21.1 million year-over-year).
Cash and financial assets at 30 June 2025 totaled $84.1 million, with a pro-forma cash balance of $277 million post-placement.
No dividends declared or paid.
Outlook and guidance
Well-funded to support ongoing clinical trials and regulatory submissions through FY2026.
Focus remains on progressing SAR-bisPSMA, SARTATE, and SAR-Bombesin towards commercialisation, with additional assets in the pipeline.
Anticipates further clinical data readouts and potential Phase III trial initiations in the coming year.
Impact of strategic reprioritization on pipeline?
Cu-64 SARTATE's edge over Ga-68 DOTATATE?
How does TCT production avoid Lu-177 issues?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Clarity Pharmaceuticals earnings date
AGM 202525 Nov, 2025
Next Clarity Pharmaceuticals earnings date
AGM 202525 Nov, 2025
The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Clarity Pharmaceuticals Ltd is a radiopharmaceutical company specializing in the development of targeted theranostic products for the diagnosis and treatment of serious diseases, particularly cancer. Utilizing its proprietary platform technology, the company develops products that combine diagnostic imaging and therapeutic capabilities, allowing for precise targeting of cancer cells with minimal impact on surrounding healthy tissues. The company is headquartered in Sydney, Australia, and its shares are listed on the Australian Securities Exchange.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage